Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Special Diversified Opportunities Inc (SDOI)

Special Diversified Opportunities Inc (SDOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Special Diversified Opportunities Inc 1521 CONCORD PIKE SUITE 301 WILMINGTON DE 19803 USA

www.spdopps.com P: 302-824-7062

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

Special Diversified Opportunities Inc is a Delaware corporation Incorporated in 1990. The Life Sciences Business constituted its only operating business, and accordingly, following the closing of the Asset Sale, the Company has become a 'shell company' under the federal securities laws. Prior to the completion of the Asset Sale, the Company was a biotechnology company engaged in developing, commercializing and marketing proprietary products, services and solutions that preserve and enhance the quality of human health and wellness. The Company provided various life sciences products and services, including custom antibodies, in-vitro diagnostic-grade antibodies, proprietary critical reagent products, associated bio-processing services, and custom assay design and development services. The Company's products and services were sold to, and often incorporated in the production process for other commercial products used by various customers including pharmaceutical, biotechnology and diagnostic companies, and major biomedical research centers both domestically and internationally. The Company's Genomic Antibody Technology ('GAT') was used in proteomic research, disease understanding and drug/biomarker discovery among academic, biotech, in-vitro diagnostic ('IVD') and pharmaceutical customers.

Key Statistics

Overview:

Market Capitalization, $K 18,305
Shares Outstanding, K 21,040
Annual Sales, $ 0 K
Annual Net Income, $ -3,030 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,230 K
60-Month Beta 0.40
% of Insider Shareholders 37.30%
% of Institutional Shareholders 0.32%

Growth:

1-Year Return -5.43%
3-Year Return -26.89%
5-Year Return -38.30%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -39.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/11/17
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Qtr 45.45%
EPS Growth vs. Prev Year -500.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SDOI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -19.32%
Return-on-Assets % -18.35%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.92
Book Value/Share 0.90
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar